DURAK ARAS, B. Et Al. 2019. Evaluating the frequencies of EGRF, ALK/EML4 and ROS1 Alterations in Lung Cancer: A Single-Center Experience.. European Human Genetics Conference , (Gothenburg, Sweden), 1117.

DURAK ARAS, B., ÇİLİNGİR, O., IŞIK, S., ARSLAN, S., DÜNDAR, E., AK, G., ... ERZURUMLUOĞLU GÖKALP, E.(2019). Evaluating the frequencies of EGRF, ALK/EML4 and ROS1 Alterations in Lung Cancer: A Single-Center Experience. . European Human Genetics Conference (pp.1117). Gothenburg, Sweden

DURAK ARAS, BEYHAN Et Al. "Evaluating the frequencies of EGRF, ALK/EML4 and ROS1 Alterations in Lung Cancer: A Single-Center Experience.," European Human Genetics Conference, Gothenburg, Sweden, 2019

DURAK ARAS, BEYHAN D. Et Al. "Evaluating the frequencies of EGRF, ALK/EML4 and ROS1 Alterations in Lung Cancer: A Single-Center Experience.." European Human Genetics Conference , Gothenburg, Sweden, pp.1117, 2019

DURAK ARAS, B. Et Al. (2019) . "Evaluating the frequencies of EGRF, ALK/EML4 and ROS1 Alterations in Lung Cancer: A Single-Center Experience.." European Human Genetics Conference , Gothenburg, Sweden, p.1117.

@conferencepaper{conferencepaper, author={BEYHAN DURAK ARAS Et Al. }, title={Evaluating the frequencies of EGRF, ALK/EML4 and ROS1 Alterations in Lung Cancer: A Single-Center Experience.}, congress name={European Human Genetics Conference}, city={Gothenburg}, country={Sweden}, year={2019}, pages={1117} }